Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1-Reference-Cited by-同舟云学术

Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1

Published:2011-02-07 Issue:9 Volume:20 Page:1738-1750
ISSN:1460-2083
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Chan Wing Man,Tsoi Ho,Wu Chi Chung,Wong Chi Hang,Cheng Tat Cheung,Li Hoi Yeung,Lau Kwok Fai,Shaw Pang Chui,Perrimon Norbert,Chan Ho Yin Edwin

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/20/9/1738/17254731/ddr049.pdf

Reference62 articles.

1. Trinucleotide repeat disorders;Orr;Annu. Rev. Neurosci.,2007

2. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence;Bichelmeier;J. Neurosci.,2007

3. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice;Klement;Cell,1998

4. C-termini of P/Q-type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity;Kordasiewicz;Hum. Mol. Genet.,2006

5. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity;Nucifora;J. Biol. Chem.,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endosome mediated nucleocytoplasmic trafficking and endomembrane allocation is crucial to polyglutamine toxicity;Cell Biology and Toxicology;2024-06-20

2. Increased Karyopherin Alpha Levels Attenuate Mutant Ataxin-1-Induced Neurodegeneration;2023-07-14

3. Gene Alterations Induced by Glutamine (Q) Encoding CAG Repeats Associated with Neurodegeneration;Methods in Molecular Biology;2022-10-28

4. Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets;Cellular and Molecular Life Sciences;2022-05

5. Karyopherin abnormalities in neurodegenerative proteinopathies;Brain;2021-05-21